Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar

Glenmark Pharmaceuticals informs about media release

23 Aug 2019

Glenmark Pharmaceuticals has informed about media release titled: ‘Glenmark Pharmaceuticals receives ANDA approval for Fulvestrant Injection, 250 mg/5 mL (50 mg/mL)’.

The above information is a part of company’s filings submitted to BSE.

Related Glenmark Pharmaceuticals Ltd. Links:

Glenmark Pharma Share Price

652.60 18.85 (2.97%) Jun 11, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 681.25
Dr. Reddys Lab 5451.20
Lupin 1230.25
Piramal Enterprises 2252.60
Cadila Healthcare 665.00
View more..
Sensex vs Glenmark Pharma
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback